Claims have surfaced about the late actor Matthew Perry and his reported involvement with the illegal purchase of ketamine in the weeks leading up to his death. A distribution of information circulating online cites RadarOnline as the source of these allegations, describing a period when Perry was said to have spent a substantial sum on the drug. The reports suggest that a total of 55 ketamine bottles were obtained over a span of 29 days, raising questions about the extent of the use and its possible impact on the actor’s health at the time.
According to the accounts presented by the outlet, the supplier identified in the narrative was Dr. Salvador Plasencia, who allegedly sold the drug to the actor. The narrative further claims that a message from Plasencia to a colleague, Dr. Mark Chavez, indicated a concern about obtaining additional ketamine. The message reportedly included a remark about the willingness of the buyer to pay for the supply, adding to the sensational elements of the tale that have circulated since Perry’s death.
News surrounding Perry’s death notes that the actor, aged 54, was found in the pool at his Los Angeles residence on October 28, 2023. An autopsy report is said to have concluded that ketamine contributed to deteriorating health, which culminated in a heart event. The reporting emphasizes a sequence of events in which Perry reportedly received multiple doses within a short time frame, with a request for a third, larger dose marking what the accounts describe as a final consumption episode.
In the wake of the tragedy, investigators and law enforcement teams were described as moving forward with their inquiries. The accounts suggest that Perry’s routine and the circumstances surrounding his medication use became a focal point for those reviewing the case. The conversations and messages attributed to the involved medical professionals allegedly highlighted the tension between access to controlled substances and the responsibilities of those who dispense or administer them. The overall implication, as presented by the reports, is that these factors may have intersected with Perry’s health in the days leading up to the death.
As the investigation progressed, family members were mentioned in later summaries as extending thanks to authorities while awaiting the full results of the inquiry. The narrative notes that once police and investigative teams identified those involved and proceeded with their work, public attention intensified around the nuances of Perry’s life and the pressures that may have shaped his experiences during that period. The aim of sharing these details appears to be to provide a fuller picture of the events that surrounded the actor’s passing, while acknowledging the complexity and sensitivity of the information involved.
It is important to recognize that the information cited here represents reported claims from entertainment outlets and not verified, official statements. Readers are encouraged to consider the context, seek corroboration from credible sources, and remember that the focus of ongoing investigations is to establish a factual chronology while respecting the privacy and memory of all individuals affected by the case. The coming weeks and months may bring updates that clarify the role, if any, that ketamine possession and use played in the broader health narrative surrounding the actor’s death, as well as the responsibilities of those connected to any medical administration involved in the period prior to the tragedy. The aim remains to present a careful, balanced account that informs without sensationalizing what is a deeply personal and tragic event.